Featured Research

from universities, journals, and other organizations

Researchers Discover Human Gene That May Produce Sweet Taste Receptor

Date:
April 26, 2001
Source:
Howard Hughes Medical Institute
Summary:
Two research groups led by Howard Hughes Medical Institute (HHMI) investigators have independently identified a human gene that encodes a likely receptor for sweet compounds. The researchers say finding the gene, which is expressed by the tongue’s taste cells, opens an important research pathway that may help answer fundamental questions such as how the brain perceives sweet taste and why molecules with dramatically different chemical structures can taste sweet.

April 23, 2001 — Two research groups led by Howard Hughes Medical Institute (HHMI) investigators have independently identified a human gene that encodes a likely receptor for sweet compounds. The researchers say finding the gene, which is expressed by the tongue’s taste cells, opens an important research pathway that may help answer fundamental questions such as how the brain perceives sweet taste and why molecules with dramatically different chemical structures can taste sweet. Discovery of the candidate sweet taste receptor adds to a repertoire of recently discovered receptors thought to be involved in the perception of bitter and umami tastes.

Discovery of the candidate sweet receptor gene, called T1r3, was reported in articles published in the May 2001 issue of Nature Neuroscience by HHMI’s Linda Buck and colleagues at Harvard Medical School; and in the May 2001 issue of Nature Genetics by HHMI’s Robert F. Margolskee and colleagues at the Mount Sinai School of Medicine at New York University.

Taste receptors are proteins that nestle in the surface of taste bud cells and bind to specific chemicals. When the appropriate chemical activates a taste receptor, it launches a cascade of molecular events that culminates in the brain’s perception of taste information.

The starting point for both research groups was the Sac locus in the mouse genome —a region of mouse chromosome 4 known to govern the preference for sweet tasting substances.

"The Sac locus in mice was known to be the most important determinant for differentiating ‘taster’ strains of mice that preferred sweetened solutions from ‘non-taster’ strains that didn’t prefer a sweetened solution over plain water," said Margolskee. "But we didn’t know whether the Sac locus was one gene or multiple genes, or a genetic control element."

Margolskee’s group built on earlier studies by Alexander Bachmanov and Gary Beauchamp of the Monell Chemical Senses Center that had narrowed the location of the Sac locus to a small chromosome region near a known marker. Once Margolskee’s team located the homologous marker in human DNA, "we put together a contiguous region of about a million base pairs of DNA around this marker using both finished human sequence and unfinished high throughput human sequences," said Margolskee. In fact, since the human genome sequence in that region had not yet been completed, the scientists had to fit the pieces together themselves, like a jigsaw puzzle, to create an organized search region.

Within this contiguous human genome sequence, the researchers discovered numerous genes. But only one coded for a protein that fit their working assumption that the Sac gene product should be a signal transduction component such as a G protein-coupled receptor (GPCR).

Buck and her colleagues used a different approach in searching for a GPCR near the Sac locus. "We first determined where the region corresponding to the mouse Sac locus was in humans and looked for genes encoding G protein-coupled receptors in that region," said Buck. "In the finished human genome database, we didn’t find anything, but in the draft sequence, we found a piece of DNA that would fit in that region, and which had a gene encoding what appeared to be a GPCR." Studies by Buck and her colleagues revealed that the gene was related to similar previously identified genes, called T1r1 and T1r2 that had been found in taste cells, but whose taste-reception function was unknown. T1r1 and T1r2 had been previously identified by HHMI investigator Charles Zuker at the University of California, San Diego and Nicholas Ryba at the National Institutes of Health.

Both Buck and Margolskee’s group named the potential sweet receptor gene product T1r3, for "taste receptor family 1, member 3."

"This receptor really shouted out to us as a strong candidate to be the Sac gene and to be a sweet receptor, because of its similarity to T1r1 and T1r2," said Margolskee. Also, the T1r3 protein has a large extracellular loop that juts outside the cell membrane, as would be required for a receptor that had evolved to attach to large carbohydrate sugar molecules, said Margolskee. Importantly, studies of T1r3 expression by both groups confirmed that the gene was selectively expressed in the membranes of taste cells and not in other cells in the tongue or elsewhere in the body.

"This protein is physically in the taste cell where it ought to be if it is the Sac protein," said Margolskee. "And within the taste cells, it’s in the apical membranes, where a sweet receptor should be."

Both teams of scientists had predicted that the T1r3 gene would show sequence differences between sweet-preferring taster mice and sweet-indifferent non-taster mice. And, indeed, they did find such differences in gene sequence between the strains that argued for the gene’s role in sweet tasting. In a molecular model of the structure of T1r3, Margolskee and colleagues identified a specific amino acid sequence in the non-taster T1r3 protein that is predicted to add a new carbohydrate group at a portion of the receptor likely to be critical for its function.

In a discovery that hinted at how very different molecules might trigger the sweet taste sensation, Buck and her colleagues found that the majority of mouse taste bud cells that expressed T1r3 also expressed T1r2.

"We find the co-expression of these two genes extremely intriguing," said Buck. "It implies that individual taste cells are probably recognizing at least two tastes. They might be functioning independently as taste receptors; or the receptor proteins might interact to form various combinations that give the opportunity to recognize different sweeteners."

Buck and Margolskee—whose laboratories are now exploring the molecular function of the candidate sweet receptor—emphasize that such work could have important clinical benefits.

"A large percentage of people in the United States and other western countries are overweight. And the artificial sweeteners now used in an attempt to control weight just don’t do a very good job of mimicking the taste of the natural sweetener," said Margolskee. "Until now, developing those sweeteners has been a hit-or-miss proposition; but if we understood the sweet receptor and its binding mechanism, we could design a sweetener molecule that would fit perfectly and be a million times more potent than sugar yet have the same sweetness as a natural sugar sweetener.

"Also, the loss of the sense of taste is a major quality-of-life problem for the elderly, and one that can contribute to malnutrition," said Margolskee. "If we could enhance the activity of taste receptors, including those for sweet and amino acids, it might help patients with nutritional problems."

Buck emphasized that identifying the sweet receptor offers an important pathway for exploring how the brain processes taste information. "If you have genes that code for receptors that recognize particular tastes such as sweet versus bitter, you can use those genes as tools to actually visualize what’s happening inside the brain. For example, is there a sweet spot in the brain, a bitter spot, or a sour spot?" Furthermore, researchers would be able to explore whether the olfactory and taste senses—long known to function in concert—share neural circuitry.


Story Source:

The above story is based on materials provided by Howard Hughes Medical Institute. Note: Materials may be edited for content and length.


Cite This Page:

Howard Hughes Medical Institute. "Researchers Discover Human Gene That May Produce Sweet Taste Receptor." ScienceDaily. ScienceDaily, 26 April 2001. <www.sciencedaily.com/releases/2001/04/010424074013.htm>.
Howard Hughes Medical Institute. (2001, April 26). Researchers Discover Human Gene That May Produce Sweet Taste Receptor. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2001/04/010424074013.htm
Howard Hughes Medical Institute. "Researchers Discover Human Gene That May Produce Sweet Taste Receptor." ScienceDaily. www.sciencedaily.com/releases/2001/04/010424074013.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins